The safety and effectiveness of rehabilitation exercises on COVID-19 patients A protocol for systematic review and meta-analysis6600 Published on 2020-07-312022-10-30 Journal: Medicine [Category] COVID-19, SARS, [키워드] Affect change Chinese clinical clinical heterogeneity Cochrane Library Corona COVID-19 COVID-19 patient COVID-19 patients daily living Diseases Effect effective Effectiveness Efficiency Evidence exclusion criteria funnel heterogeneity IMPROVE Inclusion Infrastructure journal literature Meta-analysis outcomes Patient Primary outcomes protocol Pulmonary function random effect model registry rehabilitation rehabilitation exercises researcher Respiratory function Respiratory system retrieved Secondary outcomes sensitivity analysis statistical analysis subgroup analysis systematic review Web of Science WHO [DOI] 10.1097/MD.0000000000021373 PMC 바로가기 [Article Type] 6600
RECOVERY- Respiratory Support: Respiratory Strategies for patients with suspected or proven COVID-19 respiratory failure; Continuous Positive Airway Pressure, High-flow Nasal Oxygen, and standard care: A structured summary of a study protocol for a randomised controlled trialLetter Published on 2020-07-292022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] age allocation concealment anticipated ARMS Blinding Care clinical clinically comparator Complete computer-generated conducted Continuous Continuous Positive Airway Pressure COVID-19 CPAP Critical care current death decision determine dissemination effective Effectiveness element eligible England Escalation exclusion criteria Face mask fraction Gender group-sequential HFNO High-flow nasal oxygen hospital Hospital stay include inclusion criteria Inpatient Intervention intubate intubation intubation rate invasive ventilation Ireland ISRCTN maintain mechanical ventilation Mortality mortality rate nasal nasal oxygen number objective Open-label outcome outcomes oxygen oxygen inhalation therapy Palliation parallel group participant Patient performed peripheral oxygen saturation plan positive airway pressure Pragmatic pressure Primary outcome protocol Public randomisation randomised randomised controlled randomised controlled trial Randomized receive recovery reported required researcher respiratory Respiratory failure risk Sample size secondary secondary outcome sequence Standard standard care standard oxygen therapy status Strategy stratified Study protocol System therapy tracheal Treatment Trial Version website Withdrawal [DOI] 10.1186/s13063-020-04617-3 PMC 바로가기 [Article Type] Letter
Clinical and Ethical Considerations in Allocation of Ventilators in an Influenza Pandemic or Other Public Health Disaster: A Comparison of the 2007 and 2015 New York State Ventilator Allocation GuidelinesConcepts in Disaster Medicine Published on 2020-07-142022-10-31 Journal: Disaster Medicine and Public Health Preparedness [Category] Coronavirus, MERS, SARS, [키워드] acute respiratory distress Adults allocation Care clinical clinical assessments Clinical data coronavirus disease COVID-19 COVID-19 pandemic COVID-19/coronavirus criteria Department Disaster planning draft exclusion criteria force form guideline highest Influenza influenza pandemic law life likelihood New York Organ failure Other pandemic protocol protocols provided Public released retained short-term survival SOFA state Triage ventilator ventilator therapy [DOI] 10.1017/dmp.2020.232 PMC 바로가기 [Article Type] Concepts in Disaster Medicine
Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients – mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 – Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trialICu 전 환자의 Covid-19에 대한 용도 변경 면역조절 약물 - Covid-19로 입원한 ICu 전 환자에 대한 다중 암 치료 연구 – 용도 변경 약물(TACTIC-R): 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2020-07-082022-08-13 Journal: Trials [Category] SARS, 임상, [키워드] Administered Admission age Analysis Arm ARMS balloon pump balloon pump) Baricitinib baseline blinded Blinding calculated Cambridge Cambridge University Hospitals NHS Foundation Trust can not candidate cardiac clearance clinical picture college comparator comparison Complete COVID-19 infection creatinine creatinine clearance CRP Data analysis Data monitoring committee Day death defined determine diabetes Diagnosis discharge disease dissemination dose drug Drug evaluation Efficacy element enrolled envelope EU Clinical Trial EU Clinical Trials EudraCT event exclusion criteria feature fixed foundation Gault Gender hypertension IDMC immunomodulatory immunomodulatory drug immunomodulatory drugs Immunomodulatory therapies immunomodulatory therapy incidence include Inclusion independent data monitoring committee initial Inotropes interim analysis Intervention intravenously Invasive mechanical ventilation investigator ISRCTN late stage Local male membrane neutrophil Neutrophils NHS number objective on admission once daily Open-label open-label trial opinion Organ failure organ support outcome Oxygenation participant Patient phase Platform trial positive positive COVID-19 predicted Primary outcome progression Prophylaxis protocol Radiographic radiological randomisation randomised randomised controlled trial Ravulizumab recruited recruitment reduce reduced regimen Registered related disease renal renal failure Repurposed drugs risk Sample size scalability selected severity SOC stage 2 Standard of care status stratified Study protocol subject Support Toxicity treatment arm Trial Trial registration triggered Trust university university hospital Venous Thromboembolism website [DOI] 10.1186/s13063-020-04535-4 PMC 바로가기 [Article Type] Letter
Systematic review of the registered clinical trials for coronavirus disease 2019 (COVID-19)Review Published on 2020-07-062022-10-30 Journal: Journal of Translational Medicine [Category] COVID-19, SARS, [키워드] 2019-nCoV center Characteristics China Chinese Chinese hospitals clinical clinical evidence clinical trial Cochrane Handbook conducted coronavirus disease COVID-19 database drugs evaluated exclusion criteria exploratory trial identify Improving Inclusion Intervention Interventional trial majority median Methodological quality New coronavirus pneumonia observation observational studies observational study outbreak outcome Patient patients performed recommendation recruit Registered Registered clinical trial Registration Research researcher Result Risk of bias Sample size searched selected small sample size statistical Study design subject systematic review the median Treatment Trial trials [DOI] 10.1186/s12967-020-02442-5 PMC 바로가기 [Article Type] Review
Impact of vitamins A, B, C, D, and E supplementation on improvement and mortality rate in ICU patients with coronavirus-19: a structured summary of a study protocol for a randomized controlled trialStudy Protocol Published on 2020-07-062022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] 1:1 Abnormalities absence Ascorbate assigned baseline Biotin block BMI body temperature Chemotherapy clinical clinical trial clinical trials Complete condition control group COVID-19 CRP CT scan definitive diagnosis dissemination Duration element eligible patient ESR evaluate exclusion criteria expected female patient Folic acid Gender HIV Hospitalization Hypothesis ICU ICU patient IL6 Imam Impact IMPROVE include inclusion criteria intensive care unit Intervention invasive Iran kidneys liver lung male mortality rate New nicotinamide Non-invasive number objective organ outcome oxygen saturation pantothenate parallel group participant participated Patient patients patients with COVID-19 PCR per day percentage phosphate Placebo polymerase chain protocol pulmonary involvement randomization Randomized Randomized controlled trial Randomly receive registry renal researcher respiratory Riboflavin Sample size severity significantly sodium SpO2 Study protocol Supplementation Support table Tehran the patient thiamine nitrate TNF-α Treatment Two-arm viral disease Vitamin vitamin A Vitamin B Vitamin C Vitamin D Vitamin E WBC website weight with COVID-19 [DOI] 10.1186/s13063-020-04547-0 PMC 바로가기 [Article Type] Study Protocol
The curative effects of shortwave diathermy on treating Novel coronavirus (COVID-19) pneumonia: A structured summary of a study protocol for a randomised controlled trialLetter Published on 2020-07-032022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] 1:1 Analysis approved baseline bleeding blinded Blinding block Blood China Chinese clinical Cognitive impairment Complete conducted contraindication control group Controlled clinical trial coronavirus COVID-19 curative dissemination Effect element evaluate evaluator exclusion criteria experimental group ground glass healthcare worker Hypothesis ICU include inclusion criteria Inflammation Intervention lactating women Lungs management manifestation mechanical ventilation multiple organ failure Mycoplasma novel nucleic acid test number objective outcome parallel group participant patchy pathogen Patient performed Pharyngeal swab Pneumonia positive primary outcome measure protocol randomised randomised controlled trial Randomized reached receiving Registered reported required Respiratory failure Sample size secondary outcome measure serum analysis Shock SIRS Standard status Study protocol Symptoms therapeutic effect therapy Tongji Hospital Treatment Trial Ultra short-wave diathermy underlying diseases vital sign website Wuhan [DOI] 10.1186/s13063-020-04534-5 PMC 바로가기 [Article Type] Letter
Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trialLetter Published on 2020-06-262022-10-29 Journal: Trials [Category] COVID-19, SARS, [키워드] 1:1 Acute Lymphoid Leukemia acute myeloid leukemia age anticipated approval approved assigned blinded blocks Breast cancer calculated Cancer cancer patient cardiac disease chemotherapeutic agent chronic pulmonary disease clinical Colon cancer company Computed tomography control group cough COVID-19 COVID-19 symptom curative intent data analyst disease dissemination Effect element examined exclusion criteria Fever FIVE follow-up period High-resolution Hydroxychloroquine IgG antibody incidence of COVID-19 include Intervention investigated Iran leukemia Lungs lymphoid lymphoma Mashhad Medical Sciences novel nucleic acid amplification number objective occur outcome parallel-group participant Patient patients performed pharmaceutical Placebo primary end point produced Prophylaxis protocol randomised randomised controlled trial randomization sequence Randomly randomly permuted blocks recruitment Registered registration date registry respiratory tract infection Sample size sensitivity Shortness of breath specific IgM status Study protocol Symptom Tablet the patient the SARS-CoV-2 virus total sample size treated Treatment Trial triple-blind two group Two-arm university website [DOI] 10.1186/s13063-020-04485-x PMC 바로가기 [Article Type] Letter
Saliva is a potential source of Covid-19, and appropriate protection measures should be applied in dental practice Reviews Published on 2020-06-262022-10-05 Journal: Evidence-based dentistry [Category] SARS, 진단, [키워드] COVID-19 dental droplet exclusion criteria Infection measure Patient professional Protective Result Saliva SARS-CoV-2 Transmission transmission route [DOI] 10.1038/s41432-020-0101-y [Article Type] Reviews
Are hydroxychloroquine and chloroquine effective in the treatment of SARS-COV-2 (COVID-19)? Reviews Published on 2020-06-262022-10-05 Journal: Evidence-based dentistry [Category] 임상, [키워드] carried Chloroquine comparable COVID-19 data extraction database drug effective Effectiveness Efficacy exclusion criteria help heterogeneity high quality evidence highlight humans Hydroxychloroquine Inclusion Interim report item limitations manuscript methodological limitations methodology narrative national guidelines non-randomised trial Open-label outcome outcomes parameters prospective cohort study randomised controlled trial Randomised controlled trials recommendation regimen reported Reporting Result review statistical analysis statistically significant difference study outcome suggested Treatment use of hydroxychloroquine were excluded [DOI] 10.1038/s41432-020-0098-2 [Article Type] Reviews